ALACHUA, FL / ACCESSWIRE / May 23, 2019 / CTD Holdings, Inc. (CTDH), a clinical stage biotechnology company that develops cyclodextrin-based products …
CTD Announces Home-Based Dosing of First Patient in US Extension Protocol of Clinical Trial using Intravenous Administration of Trappsol (R) Cyclo (TM) for Niemann-Pick Disease Type C – Yahoo Finance